All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

  1. [Screening for Colorectal Cancer : current evidence and budget impact for Belgium.]

    KCE Reports 45 (2006)

    https://kce.fgov.be/en/screening-for-colorectal-cancer-current-evidence-and-budget-impact-for-belgium

  2. [Home Monitoring of Infants in Prevention of Sudden Infant Death Syndrome]

    KCE Reports 46 (2006)

    https://kce.fgov.be/en/home-monitoring-of-infants-in-prevention-of-sudden-infant-death-syndrome

  3. HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment

    KCE Reports 64 (2007)

    https://kce.fgov.be/en/hpv-vaccination-for-the-prevention-of-cervical-cancer-in-belgium-health-technology-assessment

  4. Seasonal influenza vaccination: prioritizing children or other target groups? - Part II

    KCE Reports 204 (2013)

    https://kce.fgov.be/en/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-ii

  5. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study
  6. Children in a playground

    Cost-effectiveness analysis of HPV vaccination of boys in Belgium

    KCE Reports 308 (2019) The vaccine for the human papilloma virus (HPV) which causes cervical cancer was introduced about ten years ago in Belgium, but only girls benefit from it. However, it is now established that this same virus is also involved in other cancers, including throat cancer. The recommendations have thus been reviewed and here, as in most western countries, it is now recommended to vaccinate boys too.

    https://kce.fgov.be/en/cost-effectiveness-analysis-of-hpv-vaccination-of-boys-in-belgium